Back
Kymera Therapeutics Vs. Avidity Biosciences Industry Stock Comparison
Buy
67
KYMR
Kymera Therapeutics
Last Price:
49.80
Seasonality Move:
36.05%
Sell
28
RNA
Avidity Biosciences
Last Price:
44.49
Seasonality Move:
-1.3%
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.79. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $44.45. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $44.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 60.95 | Buy |
| Chaikin Money Flow: | 714664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.35 - 48.65) | Buy |
| Bollinger Bands (100): | (33.45 - 45.77) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 56.43 | Buy |
| Chaikin Money Flow: | -1063434 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.19 - 44.61) | Buy |
| Bollinger Bands (100): | (30.59 - 45.47) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.08 | Buy |
| 20-day SMA: | 47.29 | Buy |
| 50-day SMA: | 45.16 | Buy |
| 200-day SMA: | 36.65 | Buy |
| 8-day EMA: | 47.74 | Buy |
| 20-day EMA: | 46.8 | Buy |
| 50-day EMA: | 44.35 | Buy |
| 200-day EMA: | 36.97 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.78 | Buy |
| 20-day SMA: | 42.47 | Buy |
| 50-day SMA: | 43.82 | Buy |
| 200-day SMA: | 27.14 | Buy |
| 8-day EMA: | 43.36 | Buy |
| 20-day EMA: | 42.87 | Buy |
| 50-day EMA: | 41.94 | Buy |
| 200-day EMA: | 30.63 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
Kymera Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||